Gregory A. Winchell, PhD

Owner
Winchell Pharma Consulting LLC

Disclosure(s): Certara: Advisor/Consultant; Merck: Stocks/Bonds (Public Company); Venatorx: Advisor/Consultant

Poster(s):

• (P-1230) Dose-Escalation Study to Evaluate the Pharmacokinetics and Safety of Single and Repeat Doses of Ceftibuten in Healthy Participants
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT